Neurotech’s NT-501 BLA for MacTel Treatment Delayed for Additional FDA Review
On November 8, 2024, Neurotech Pharmaceuticals (Cumberland, RI, USA), a biotechnology company focused on sustained drug delivery for chronic retinal…
On November 8, 2024, Neurotech Pharmaceuticals (Cumberland, RI, USA), a biotechnology company focused on sustained drug delivery for chronic retinal…